Measurement of tumor hypoxia in spontaneous canine sarcomas

Veterinary Radiology and Ultrasound

Volumn 46, Issue 4, 2005, Pages 348-354

  Bruehlmeier, Matthias ^c   Kaser Hotz, Barbara ^a   Achermann, Roger ^a   Bley, Carla Rohrer ^a   Wergin, Melanie ^a   Schubiger, Pius A ^b   Ametamey, Simon M ^b  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b ETH Zurich   (Switzerland)

^c CANTONAL HOSPITAL AARAU   (Switzerland)

Author keywords

18F fluoromisonidazole; Hypoxia; Positron emission tomography; Spontaneous canine sarcoma

Indexed keywords

1 FLUORO 3 (2 NITRO 1 IMIDAZOLYL) 2 PROPANOL; DRUG DERIVATIVE; FLUORINE; MISONIDAZOLE; RADIOSENSITIZING AGENT;

ANIMAL; ANIMAL DISEASE; ANOXIA; ARTICLE; CLASSIFICATION; DOG; DOG DISEASE; METABOLISM; POSITRON EMISSION TOMOGRAPHY; SARCOMA; TRANSCUTANEOUS OXYGEN MONITORING;

ANIMALS; ANOXIA; BLOOD GAS MONITORING, TRANSCUTANEOUS; DOG DISEASES; DOGS; FLUORINE RADIOISOTOPES; MISONIDAZOLE; POSITRON-EMISSION TOMOGRAPHY; RADIATION-SENSITIZING AGENTS; SARCOMA;

ANIMALIA; CANIS FAMILIARIS;

EID: 26244464037     PISSN: 10588183     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1740-8261.2005.00065.x     Document Type: Article

References (24)

1. Nias AHW. An introduction to radiobiology, 2nd ed. London: Willey & Sons, 1998.
2. Airley RE, Monaghan JE, Stratford IJ. Hypoxia and disease: oppurtunities for novel diagnostic and therapeutic prodrug strategies. Pharmaceut J 2000;264:666-673.
3. Dewhirst MW, Kimura H, Rehmus SW, et al. Microvascular studies on the origins of perfusion-limited hypoxia. Br J Cancer 1996:27(Suppl):S247-S251.
4. Chapman JD. Measurement of tumor hypoxia by invasive and non-invasive procedures: a review of recent clinical studies. Radiother Oncol 1991;20(Suppl 1):13-19.
5. Gray LH, Conger AD, Ebert M, Hornsey S, Scott OCA. The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy. Br J Radiol 1953;26:638-648.
6. Ikeda E, Achen MG, Breier G, Risau W. Hypoxia-induced transcriptional activation and increased mRNA stability of vascular endothelial growth factor in C6 glioma cells. J Biol Chem 1995;270:19761-19766.
7. Chapman JD, Engelhardt EL, Stobbe CC, Schneider RF, Hanks GE. Measuring hypoxia and predicting tumor radioresistance with nuclear medicine assays. Radiother Oncol 1998;46:229-237.
8. Rasey JS, Koh WJ, Grierson JR, Grunbaum Z, Krohn KA. Radiolabelled fluoromisonidazole as an imaging agent for tumor hypoxia. Int J Radiat Oncol Biol Phys 1989;17:985-991.
9. Lewis J, Laforest R, Buettner T, et al. Copper-64-diacetyl-bis(N4- methylthiosemicarbazone): an agent for radiotherapy. Proc Natl Acad Sci USA 2001;98:1206-1211.
10. Gronroos T, Eskola O, Lehtio K, et al. Pharmacokinetics of [18F]FETNIM: a potential marker for PET. J Nucl Med 2001;42:1397-1404.
11. Dolbier WR Jr., Li AR, Koch CJ, Shiue CY, Kachur AV. [18F]-EF5, a marker for PET detection of hypoxia: synthesis of precursor and a new fluorination procedure. Appl Radiat Isot 2001;54:73-80.
12. Lehtio K, Oikonen V, Nyman S, et al. Quantifying tumour hypoxia with fluorine-18 fluoroerythronitroimidazole ([(18)F]FETNIM) and PET using the tumour to plasma ratio. Eur J Nucl Med Mol Imag 2003;30:101-108.
13. Rasey JS, Koh WJ, Evans ML, et al. Quantifying regional hypoxia in human tumors with positron emission tomography of [18F]fluoromisonidazole: a pretherapy study of 37 patients. Int J Radiat Oncol Biol Phys 1996;36:417-428.
14. Rischin D, Peters L, Hicks R, et al. Phase I trial of concurrent tirapazamine, cisplatin, and radiotherapy in patients with advanced head and neck cancer. J Clin Oncol 2001;19:535-542.
15. Whitmore GF, Varghese AJ. The biological properties of reduced nitroheterocyclics and possible underlying biochemical mechanisms. Biochem Pharmacol 1986;35:97-103.
16. Fenton BM, Lord EM, Paoni SF. Intravascular HBO(2) saturations, perfusion and hypoxia in spontaneous and transplanted tumor models. Int J Cancer 2001;93:693-698.
17. Lim JL, Berridge MS. An efficient radiosynthesis of [18F] fluoromisonidazole. Appl Radiat Isot 1993;44:1085-1091.
18. Patlak CS, Blasberg RG, Fenstermacher JD. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. J Cereb Blood Flow Metab 1983;3:1-7.
19. Mikolajczyk K, Szabatin M, Rudnicki P, Grodzki M, Burger C. A JAVA environment for medical image data analysis: initial application for brain PET quantitation. Med Inform (London) 1998;23:207-214.
20. Achermann R, Ohlerth S, Fidel J, et al. Ultrasound guided, pre-radiation oxygen measurements using polarographic oxygen needle electrodes in spontaneous canine soft tissue sarcomas. In Vivo 2002;16:431-437.
21. Achermann R, Ohlerth SM, Rohrer Bley C, et al. Oxygenation of spontaneous canine tumors during fractionated radiation therapy. Strahlenther Onkol 2004;180:297-305.
22. Vaupel P, Thews O, Kelleher DK, Hoeckel M. Oxygenation of human tumors: the Mainz experience. Strahlenther Onkol 1998;174 (Suppl 4):6-12.
23. 2O. J Nucl Med 2004;45:1851-1859.
24. Gross MW, Karbach U, Groebe K, Franko AJ, Mueller-Klieser W. Calibration of misonidazole labeling by simultaneous measurement of oxygen tension and labeling density in multicellular spheroids. Int J Cancer 1995;61:567-573.